Assessment of treatment efficacy of diphenylcyclopropenone (DPCP) for alopecia areata

KUTLUBAY Z., Sevim Kecici A., Aydin O., Vehid S., Serdaroglu S.

TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.50, sa.8, ss.1817-1824, 2020 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 50 Sayı: 8
  • Basım Tarihi: 2020
  • Doi Numarası: 10.3906/sag-1807-230
  • Dergi Adı: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.1817-1824
  • Anahtar Kelimeler: Alopecia areata, topical immunotherapy, diphenylcyclopropenone, TOPICAL IMMUNOTHERAPY, PROGNOSTIC-FACTORS, IMMUNE PRIVILEGE, HAIR FOLLICLE, DIPHENCYPRONE, COMBINATION, SAFETY
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır

Özet

Background/aim: Alopecia areata (AA) is an inflammatory disease with a genetic and autoimmtme basis. Herein, it was aimed to study the efficacy and safety of an immunomodulatory therapeutic agent, diphenylcyclopropenone, while manifesting its association with histopathological features, prognostic factors, and side effects.